Studies in depression show decreased H2K9ac at BDNF, in schizophrenia where H3K27me3 is modified at GAD1, in PTSD with repressive marks on FKBP5, and in addiction where changes in H3 acetylation impact reward circuits (27). Here, GAD1 is linked to depressive symptom measurement.